A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy

Abstract EN

Shen-Qi-Di-Huang decoction (SQDHD), a well-known herbal formula from China, has been widely used in the treatment of diabetic nephropathy (DN).

However, the pharmacological mechanisms of SQDHD have not been entirely elucidated.

At first, we conducted a comprehensive literature search to identify the active constituents of SQDHD, determined their corresponding targets, and obtained known DN targets from several databases.

A protein-protein interaction network was then built to explore the complex relations between SQDHD targets and those known to treat DN.

Following the topological feature screening of each node in the network, 400 major targets of SQDHD were obtained.

The pathway enrichment analysis results acquired from DAVID showed that the significant bioprocesses and pathways include oxidative stress, response to glucose, regulation of blood pressure, regulation of cell proliferation, cytokine-mediated signaling pathway, and the apoptotic signaling pathway.

More interestingly, five key targets of SQDHD, named AKT1, AR, CTNNB1, EGFR, and ESR1, were significant in the regulation of the above bioprocesses and pathways.

This study partially verified and predicted the pharmacological and molecular mechanisms of SQDHD on DN from a holistic perspective.

This has laid the foundation for further experimental research and has expanded the rational application of SQDHD in clinical practice.